Randomized phase II study of TS-1 [S-1] therapy and TS-1+PSK [polysaccharide K] therapy against unresectable advanced gastric carcinoma and recurrent gastric carcinoma
Phase of Trial: Phase II/III
Latest Information Update: 22 Jan 2009
At a glance
- Drugs Polysaccharide K (Primary) ; Gimeracil/oteracil/tegafur
- Indications Gastric cancer
- Focus Therapeutic Use
- 22 Jan 2009 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 22 Jan 2009 Planned patient number changed from 120 to 13 as reported by ClinicalTrials.gov.
- 16 Aug 2007 New trial record.